January 30, 2014

Research for AIDS Cure Advances as HIV Fought in Monkeys
October 30, 2013

Achieving an AIDS-free World: Science and Implementation
October 21, 2013

HIV-AIDS: Much Accomplished, Much to Do
October 21, 2013

Valneva announces new EB66® clinical development license agreement with International AIDS Vaccine Initiative for preventive HIV vaccine
October 2, 2013

Study Explores Barriers to HIV Vaccine Response
September 30, 2013

AVAC Evaluates Range of Vaccine Trials Across the World
September 27, 2013

Promising OHSU study shows immune clearance of highly pathogenic SIV infection
September 11, 2013

Scientist identifies helper cells that trigger potent responses to HIV
September 10, 2013

Continued investment in HIV prevention research can speed development of new options to help end the AIDS epidemic
June 30, 2013

U.S. Secretary of State John Kerry to commemorate PEPFAR's 10th anniversary on 18 June
June 2013

Global Health Network launches “Site Finder” to facilitate global health research collaborations in developing countries
June 2013

In Memoriam: Dr. Chris Scanlan, our colleague and friend at the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, 1977-2013 
May 2013

VOICE Trial Results Underscore Need to Accelerate Development of Additional HIV Prevention Options for Women
March 2013

AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
November 2012

CAPRISA: Study discovers a unique feature of HIV that enables infected people to make antibodies able to kill a wide range of human immunodeficiency viruses
October 22, 2012

HIV Vaccines and Microbicides Resource Tracking Working Group report calls for sustained funding of HIV prevention research
July 23, 2012

AIDS 2012 Conference Plenary—Ending the Epidemic: Turning the Tide Together
July 23, 2012

NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery
July 11, 2012

Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
April 4, 2012

GHTC 2012 Policy Report
February 28, 2012